TRAVELLI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 314
EU - Europa 178
AS - Asia 20
OC - Oceania 2
Totale 514
Nazione #
US - Stati Uniti d'America 314
IE - Irlanda 123
IT - Italia 40
CN - Cina 18
BE - Belgio 8
DE - Germania 3
AU - Australia 2
FI - Finlandia 2
GB - Regno Unito 1
SE - Svezia 1
TR - Turchia 1
TW - Taiwan 1
Totale 514
Città #
Dublin 123
Chandler 113
Ashburn 42
Shanghai 17
Ann Arbor 15
Lawrence 15
Princeton 15
Medford 11
Bolzaneto 9
Wilmington 9
Brussels 8
Chicago 6
Milan 5
Bossico 4
New York 4
Norwalk 4
Washington 4
Des Moines 2
Helsinki 2
Treviglio 2
Adelaide 1
Boardman 1
Cambridge 1
Los Angeles 1
Pinerolo 1
Rome 1
San Francisco 1
Seattle 1
Sydney 1
Taipei 1
Trezzano sul Naviglio 1
Totale 421
Nome #
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression 50
Ribosomes as a nexus between translation and cancer progression: Focus on ribosomal Receptor for Activated C Kinase 1 (RACK1) in breast cancer 41
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma 40
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 36
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 36
Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells 35
Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 34
A nicotinamide phosphoribosyltransferase–GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus 32
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity 32
The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5) 30
Design, synthesis, and biological evaluation of combretabenzodiazepines: A novel class of anti-tubulin agents 30
Prostaglandin E2 and cancer: Insight into tumor progression and immunity 26
Mucosal Overexpression of Thymic Stromal Lymphopoietin and Proinflammatory Cytokines in Patients With Autoimmune Atrophic Gastritis 23
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group 23
Molecular characterization of membrane steroid receptors in hormone-sensitive cancers 23
Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy 21
Molecular regulations of circadian rhythm and implications for physiology and diseases 18
NAMPT: A pleiotropic modulator of monocytes and macrophages 17
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis 6
The NAMPT inhibitor FK866 reverts the damage in spinal cord injury 4
Extracellular nicotinamide phosphoribosyltransferase boosts IFNγ-induced macrophage polarization independently of TLR4 1
eNAMPT/TLR4 inflammatory cascade activation is a key contributor to SLE Lung vasculitis and alveolar hemorrhage 1
Metabolic regulation of suppressive myeloid cells in cancer 1
Involvement of eNAMPT/TLR4 inflammatory signaling in progression of non-alcoholic fatty liver disease, steatohepatitis, and fibrosis 1
Synthesis and Degradation of Adenosine 5′-Tetraphosphate by Nicotinamide and Nicotinate Phosphoribosyltransferases 1
Autophagy and inflammation an intricate affair in the management of obesity and metabolic disorders: evidence for novel pharmacological strategies? 1
Triazole-curcuminoids: A new class of derivatives for 'tuning' curcumin bioactivities? 1
Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement 1
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer 1
A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry 1
NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease 1
Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine 1
Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer 1
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions 1
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 1
Characterization of NAD uptake in mammalian cells 1
NAD depletion by FK866 induces autophagy 1
Identification of novel aza-analogs of TN-16 as disrupters of microtubule dynamics through a multicomponent reaction 1
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 1
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells 1
Totale 577
Categoria #
all - tutte 3.231
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.231


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 11 0 6 0 1 1
2021/202297 1 1 1 0 2 1 0 7 5 1 10 68
2022/2023317 17 34 15 22 22 34 0 18 143 2 8 2
2023/2024108 9 13 6 11 17 29 0 20 1 1 0 1
2024/202536 36 0 0 0 0 0 0 0 0 0 0 0
Totale 577